Cytovant
Shanghai
About Cytovant
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics. The company focuses on developing modified T-cell receptor therapeutics and dendritic cell vaccines that target tumor antigens to improve tumor cells therapy and treatment.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $23.5M
- Last round: Series Unknown (Apr 2020)
- Website: cytovant.com
- Phone: +86 21 5090 0866
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cytovant-149854 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.